Search Results - V A Ionin

Resistant arterial hypertension: is it really so or have we missed something? by V. A. Ionin

Get full text

HOW TO REDUCE GASTROINTESTINAL BLEEDING RISK ON ANTICOAGULATION THERAPY IN NON-VALVULAR ATRIAL FIBRILLATION? by E. I. Baranova, А. G. Filatova, V. A. Ionin

Get full text

Antithrombotic therapy for atrial fibrillation and comorbidities — how to choose the optimal solution? by E V Schlyakhto, E I Baranova, V A Ionin

Get full text

Biomarkers of fibrosis and inflammation and the risk of arrhythmia recurrence after elective electrical cardioversion in patients with atrial fibrillation and metabolic syndrome by E. I. Barashkova, V. A. Ionin, E. I. Baranova

Get full text

Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions by V. A. Ionin, O. I. Bliznuk, E. I. Baranova, E. V. Shlyakhto

Get full text

Factors associated with inappropriate reduced doses of non-vita-min K antagonist oral anticoagulants in patients with atrial fibrillation by V. A. Ionin, O. I. Bliznuk, V. A. Pavlova, E. I. Baranova

Get full text

Nocturnal hypoxemia, cardiac remodeling, and blood concentrations of fibrosis biomarkers in patients with atrial fibrillation and obstructive sleep apnea by V. A. Berdysheva, V. A. Ionin, A. S. Vakulenko, T. A. Lozovaya, E. I. Baranova

Get full text

Safety of direct oral anticoagulants in patients with atrial fibrillation and high risk of stroke (review of literature) by E. I. Baranova, V. A. Ionin, A. A. Katsap, O. S. Kolesnik, E. V. Lebedeva

Get full text

Apelin and heart remodeling in patients with abdominal obesity by O. V. Listopad, E. A. Bazhenova, V. A. Ionin, O. D. Belyaeva, E. I. Baranova

Get full text

Role of galectin 3 and epicardial fat thickness in the development of atrial fibrillation in patients with metabolic syndrome by V. A. Ionin, O. V. Listopad, S. E. Nifontov, E. I. Baranova, A. V. Soboleva, E. V. Shlyakhto

Get full text

Molecular mechanisms of the development of atrial fibrillation in patients with type 2 diabetes mellitus: prognostic role of biomarkers of fibrosis and inflammation by V. A. Ionin, E. I. Barashkova, A. M. Ananev, V. A. Pavlova, E. L. Zaslavskaya, E. I. Baranova

Get full text

Biomarkers of inflammation, parameters characterizing obesity and cardiac remodeling in patients with atrial fibrillation and metabolic syndrome by V. A. Ionin, E. I. Baraschkova, E. L. Zaslavskaya, S. E. Nifontov, E. A. Bazhenova, O. D. Belyaeva, E. I. Baranova

Get full text

Efficiency of radiofrequency ablation of pulmonary vein ostium for patients with atrial fibrillation and metabolics by E. L. Zaslavskaya, V. A. Ionin, O. V. Listopad, S. E. Nifontov, K. N. Malikov, A. V. Soboleva, E. I. Baranova

Get full text

THE ROLE OF TRANSFORMING GROWTH FACTOR BETA-1 AND GALECTIN-3 IN FORMATION OF THE LEFT ATRIUM FIBROSIS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AND METABOLIC SYNDROME by E. L. Zaslavskaya, A. N. Morozov, V. A. Ionin, I. Ma, S. Е. Nifontov, Е. I. Baranova, S. M. Yashin, E. V. Shlyakhto

Get full text

Predictors of atrial fibrillation recurrence in patients with metabolic syndrome after pulmonary vein isolation by V. A. Ionin, E. L. Zaslavskaya, E. I. Barashkova, V. A. Pavlova, A. M. Ananev, A. N. Morozov, E. I. Baranova

Get full text

What is the role of profibrogenic and proinflammatory factors in developing atrial fibrillation associated with metabolic syndrome components? by V. A. Ionin, E. I. Barashkova, V. A. Pavlova, G. I. Borisov, K. A. Averchenko, E. L. Zaslavskaya, E. I. Baranova

Get full text

Current approaches to the treatment of hypertensive patients in view of modern guidelines by E. A. Polyakova, A. O. Konradi, E. I. Baranova, A. S. Galyavich, V. A. Ionin, O. D. Ostroumova, V. V. Skibitsky, G. A. Chumakova

Get full text

Role of epicardial adipose tissue in the development of cardiovascular diseases by I. A. Mustafina, V. A. Ionin, A. A. Dolganov, V. Sh. Ishmetov, A. E. Pushkareva, T. A. Yagudin, K. V. Danilko, N Sh. Zagidullin

Get full text

Atrial fibrillation and CHA2DS2VASc score of 1 - is there a problem in clinical practice? by E. I. Baranova, V. A. Pavlova, V. A. Ionin, E. Yu. Petrischeva, O. I. Bliznuk, E. L. Zaslavskaya, I. Ma, D. S. Skuridin, E. V. Shlakhto

Get full text

Molecular mechanisms of left atrial fibrosis development in patients with atrial fibrillation and metabolic syndrome: what biomarkers should be used in clinical practice? by V. A. Ionin, E L Zaslavskaya, E I Barashkova, V A Pavlova, G I Borisov, K A Averchenko, A N Morozov, E I Baranova, E V Schlyachto

Get full text